They include a lack of antigenic mutations, disruption of the antigen-processing machinery, loss of major histocompatibility complex (MHC) expression, and defects in interferon-γ (IFN-γ)- or tumor necrosis factor (TNF)-mediated signaling pathway that acts to increase tumor immune susceptibility (2–5). The gene discussed is TNF; the disease is neoplasm.